Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Theodoraki, Eirini V ^a   Nikopensius, Tiit ^b,f   Suhorutšenko, Julia ^b   Peppes, Vassileios ^c   Fili, Panagiota ^a   Kolovou, Genovefa ^d   Papamikos, Vassileios ^a   Richter, Dimitrios ^e   Zakopoulos, Nikolaos ^c   Krjutškov, Kaarel ^b,f   Metspalu, Andres ^b,f   Dedoussis, George V ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d ONASSIS CARDIAC SURGERY CENTER   (Greece)

^e Athens Euroclinic ^*  (Greece)

^f UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN A; FIBRINOGEN B; FIBRINOGEN BETA VARIANT; FIBRINOGEN G; FIBRINOGEN VARIANT; UNCLASSIFIED DRUG; BBETA FIBRINOGEN; FIBRINOGEN AALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GREECE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MODEL; BLOOD; CASE CONTROL STUDY; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HOMOZYGOTE; MIDDLE AGED; RECESSIVE GENE; RISK; RISK FACTOR;

ACUTE CORONARY SYNDROME; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FIBRINOGEN; GENE FREQUENCY; GENES, RECESSIVE; GENETIC VARIATION; GREECE; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77949449452     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-28     Document Type: Article

References (30)

1. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003, 89(4):601-609.
2. Reinhart WH. Fibrinogen--marker or mediator of vascular disease?. Vasc Med 2003, 8(3):211-216. 10.1191/1358863x03vm494ra, 14989564.
3. Duperray A, Languino LR, Plescia J, McDowall A, Hogg N, Craig AG, Berendt AR, Altieri DC. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997, 272(1):435-441. 10.1074/jbc.272.1.435, 8995280.
4. Harley SL, Sturge J, Powell JT. Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol 2000, 20(3):652-658.
5. Stolpe A, Jacobs N, Hage WJ, Tertoolen L, van Kooyk Y, Novakova IR, de Witte T. Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton. Thromb Haemost 1996, 75(1):182-189.
6. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279(18):1477-1482. 10.1001/jama.279.18.1477, 9600484.
7. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294(14):1799-1809. 10.1001/jama.294.14.1799, 16219884.
8. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993, 118(12):956-963.
9. Maresca G, Di Blasio A, Marchioli R, Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999, 19(6):1368-1377.
10. Kant JA, Fornace AJ, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985, 82(8):2344-2348. 10.1073/pnas.82.8.2344, 397554, 2986113.
11. Chung DW, Davie EW. gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984, 23(18):4232-4236. 10.1021/bi00313a033, 6091742.
12. Mannila MN, Eriksson P, Ericsson CG, Hamsten A, Silveira A. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction. Thromb Haemost 2006, 95(3):420-427.
13. Mannila MN, Eriksson P, Leander K, Wiman B, de Faire U, Hamsten A, Silveira A. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. J Intern Med 2007, 261(2):138-147. 10.1111/j.1365-2796.2006.01749.x, 17241179.
14. Mannila MN, Eriksson P, Lundman P, Samnegard A, Boquist S, Ericsson CG, Tornvall P, Hamsten A, Silveira A. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 2005, 93(3):570-577.
15. Carty CL, Cushman M, Jones D, Lange LA, Hindorff LA, Rice K, Jenny NS, Durda JP, Walston J, Carlson CS, et al. Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost 2008, 99(2):388-395.
16. Kardys I, Uitterlinden AG, Hofman A, Witteman JC, de Maat MP. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study. Thromb Haemost 2007, 97(2):288-295.
17. Koch W, Hoppmann P, Biele J, Mueller JC, Schomig A, Kastrati A. Fibrinogen genes and myocardial infarction: a haplotype analysis. Arterioscler Thromb Vasc Biol 2008, 28(4):758-763. 10.1161/ATVBAHA.107.157842, 18202324.
18. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 2005, 106(13):4176-4183. 10.1182/blood-2005-05-2180, 16144795.
19. Braunwald E. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997, 337(19):1360-1369. 10.1056/NEJM199711063371906, 9358131.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
21. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74(1):106-120. 10.1086/381000, 1181897, 14681826.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215. 10.1093/nar/16.3.1215, 334765, 3344216.
23. Krjutskov K, Andreson R, Magi R, Nikopensius T, Khrunin A, Mihailov E, Tammekivi V, Sork H, Remm M, Metspalu A. Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays. Nucleic Acids Res 2008, 36(12):e75. 10.1093/nar/gkn357, 2475630, 18539607.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575. 10.1086/519795, 1950838, 17701901.
25. Tregouet DA, Barbaux S, Escolano S, Tahri N, Golmard JL, Tiret L, Cambien F. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002, 11(17):2015-2023. 10.1093/hmg/11.17.2015, 12165563.
26. Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, Greven S, Salomaa V, Sunyer J, Bellander T, Chalamandaris AG, et al. Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol 2008, 52(11):941-952. 10.1016/j.jacc.2008.06.016, 18772067.
27. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997, 99(12):3034-3039. 10.1172/JCI119499, 508156, 9185528.
28. van 't Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999, 19(12):3063-3070.
29. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Buller HR, Peters RJ. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001, 104(25):3063-3068. 10.1161/hc5001.100793, 11748101.
30. Rallidis LS, Gialeraki A, Fountoulaki K, Politou M, Sourides V, Travlou A, Lekakis I, Kremastinos DT. G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece. Thromb Res 2009,